COMP <GO>
CCCC vs PROK // EV/EBITDA & P/E VALUATION
C4 Therapeutics Inc. (NASDAQ) VS. ProKidney Corp. (Class A) (NASDAQ) • 15-METRIC TALLY: CCCC 2
— PROK 1
■ METRIC PARITY
LAST: $3.37 (+2.12%) • MKT CAP: $406.0M
valuation
—
LAST: $1.30 (-11.90%) • MKT CAP: $444.4M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CCCC VS. PROK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CCCC | PROK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -24.46% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 1.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 1/9 | +2.00 | CCCC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.6 | 47.4 | +7.20 | CCCC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $406.0M | $444.4M | -$38.4M | PROK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CCCC REV | PROK REV | CCCC GROSS % | PROK GROSS % | CCCC FCF | PROK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $35.9M | $0 | — | — | -$99.3M | -$135.3M |
| FY 2024 | $35.6M | $0 | — | — | -$65.3M | -$155.9M |
| FY 2023 | $20.8M | $0 | — | — | -$106.8M | -$90.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CCCC // BETA —
PROK // BETA —